Human vaccines & immunotherapeutics: News August 2022
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Online Access: | http://dx.doi.org/10.1080/21645515.2022.2123687 |
_version_ | 1797673086821072896 |
---|---|
author | Ronald Ellis Adam Weiss |
author_facet | Ronald Ellis Adam Weiss |
author_sort | Ronald Ellis |
collection | DOAJ |
first_indexed | 2024-03-11T21:40:24Z |
format | Article |
id | doaj.art-1d5f1a1bf5ce44bab668b11dec0eecbc |
institution | Directory Open Access Journal |
issn | 2164-5515 2164-554X |
language | English |
last_indexed | 2024-03-11T21:40:24Z |
publishDate | 2022-11-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Human Vaccines & Immunotherapeutics |
spelling | doaj.art-1d5f1a1bf5ce44bab668b11dec0eecbc2023-09-26T13:19:09ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-11-0118610.1080/21645515.2022.21236872123687Human vaccines & immunotherapeutics: News August 2022Ronald Ellis0Adam Weiss1Editor-in-Chief, Biotech & BiopharmaAcquisitions Editor, Taylor & Francis Grouphttp://dx.doi.org/10.1080/21645515.2022.2123687 |
spellingShingle | Ronald Ellis Adam Weiss Human vaccines & immunotherapeutics: News August 2022 Human Vaccines & Immunotherapeutics |
title | Human vaccines & immunotherapeutics: News August 2022 |
title_full | Human vaccines & immunotherapeutics: News August 2022 |
title_fullStr | Human vaccines & immunotherapeutics: News August 2022 |
title_full_unstemmed | Human vaccines & immunotherapeutics: News August 2022 |
title_short | Human vaccines & immunotherapeutics: News August 2022 |
title_sort | human vaccines immunotherapeutics news august 2022 |
url | http://dx.doi.org/10.1080/21645515.2022.2123687 |
work_keys_str_mv | AT ronaldellis humanvaccinesimmunotherapeuticsnewsaugust2022 AT adamweiss humanvaccinesimmunotherapeuticsnewsaugust2022 |